Rolapitant for the Prevention of Postoperative Nausea and Vomiting

Abstract

Rolapitant is superior to placebo in reducing emetic episodes after surgery and reduces the incidence of vomiting in a dose-dependent manner. No differences in side effect profile were observed between rolapitant and placebo.